Outlook Therapeutics (OTLK) Consolidated Net Income (2015 - 2026)
Outlook Therapeutics' Consolidated Net Income was -$20.32 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$20.15 million a year earlier.
Powered by 
Analysis
Outlook Therapeutics (OTLK) Consolidated Net Income (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, Outlook Therapeutics' Consolidated Net Income was -$51.55 million through Jun 30, 2026; for FY2025 (ended Sep 30, 2025), it was -$62.42 million.
- In earlier fiscal years, Consolidated Net Income was -$75.37 million in FY2024, -$58.98 million in FY2023, -$66.05 million in FY2022 and -$53.16 million in FY2021.
- The fiscal Q3 2026 figure marks the lowest quarterly Consolidated Net Income since fiscal Q2 2025.
- Per Business Quant data, OTLK's Consolidated Net Income in the three fiscal quarters before Q3 2026 was -$4.45 million (Q2 2026), -$13.48 million (Q1 2026) and -$13.29 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Outlook Therapeutics | 80.68 Mn | 44.93 Mn | -8,265.00 | -20.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -20.32 Mn |
| Mar 31, 2026 | -4.45 Mn |
| Dec 31, 2025 | -13.48 Mn |
| Sep 30, 2025 | -13.29 Mn |
| Jun 30, 2025 | -20.15 Mn |
| Mar 31, 2025 | -46.36 Mn |
| Dec 31, 2024 | -21.61 Mn |
| Sep 30, 2024 | 5.69 Mn |
| Jun 30, 2024 | 44.41 Mn |
| Mar 31, 2024 | -114.29 Mn |
| Dec 31, 2023 | -10.32 Mn |
| Sep 30, 2023 | -12.99 Mn |
| Jun 30, 2023 | -20.68 Mn |
| Mar 31, 2023 | -6.65 Mn |
| Dec 31, 2022 | -15.69 Mn |
| Sep 30, 2022 | -14.35 Mn |
| Jun 30, 2022 | -17.54 Mn |
| Mar 31, 2022 | -19.70 Mn |
| Dec 31, 2021 | -13.15 Mn |
| Sep 30, 2021 | -13.40 Mn |
API Access
Outlook Therapeutics Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();